MCID: PLY018
MIFTS: 61

Polycythemia malady

Summaries for Polycythemia

About this section
Sources:
63Wikipedia, 32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
Wikipedia:63 Polycythemia (also known as polycythaemia or polyglobulia) is a disease state in which the proportion of... more...

MalaCards: Polycythemia, also known as polycythemia, nos, is related to polycythemia vera and primary polycythemia. An important gene associated with Polycythemia is CD177 (CD177 molecule), and among its related pathways are Akt Signaling and Jak-STAT signaling pathway. The compounds tyrosine and vegf have been mentioned in the context of this disorder. Affiliated tissues include bone marrow, bone and myeloid, and related mouse phenotypes are hematopoietic system and immune system.

Aliases & Classifications for Polycythemia

About this section
Sources:
8Disease Ontology, 10DISEASES, 44Novoseek, 60UMLS, 34MeSH, 56SNOMED-CT, 39NCIt
See all sources

Aliases & Descriptions:

polycythemia 8 10 44 60
polycythemia, nos 8
erythrocythemia 8
polycythaemia 8


External Ids:

Disease Ontology8 DOID:8432
MeSH34 D011086
NCIt39 C26863

Related Diseases for Polycythemia

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases in the Primary Polycythemia family:

Polycythemia Due to Hypoxia Acquired Polycythemia
polycythemia

Diseases related to Polycythemia via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 304)
idRelated DiseaseScoreTop Affiliating Genes
1polycythemia vera31.8TIMP1, EPO, EPOR, PF4, IL3, KITLG
2primary polycythemia31.0VHL, JAK2, STAT5A, EPO, EPOR
3myelofibrosis31.0THPO, EPO, JAK2
4leukemia30.8CD177, MPL, ITGB3, EPOR, PF4, EPO
5thrombocytosis30.5IFNA2, PPBP, JAK2, MPL, CD177, EPO
6acquired polycythemia30.4EPO, JAK2, EPOR
7myeloid leukemia30.4SOCS3, JAK2, MPL, IL3, KITLG, STAT5A
8hypertension30.4PPBP
9hemangioblastoma30.3VHL, EPOR, EPO
10acute leukemia30.3EPO, MPL, STAT5A, EPOR, PTPN6, ACP1
11chronic myeloid leukemia30.3EPO, CD177, MPL, ITGB3, STAT5A, JAK2
12hepatitis30.2IFNA2
13erythrocytosis30.2VHL, JAK2, MPL, CD177, EPO, EPOR
14thrombocytopenia30.1PF4, KITLG, EPO, MPL, THPO, IL3
15myocardial infarction30.1PPBP, ITGB3, PF4
16ischemia30.0PF4, SOCS3, JAK2, EPOR
17pancreatitis30.0KITLG
18myeloma29.9IFNA2, JAK2, STAT5A, EPO, EPOR, PF4
19hepatocellular carcinoma29.9EPOR, PPBP, SOCS3, IFNA2, TIMP1, ACP1
20acute myocardial infarction29.9PF4, KITLG, PPBP
21vascular disease29.9PF4, JAK2, TIMP1
22vasculitis29.9IFNA2, PPBP
23glomerulonephritis29.9EPOR
24thrombophilia29.9PPBP, PF4
25hemorrhagic thrombocythemia29.9CD177
26antiphospholipid syndrome29.9PF4
27megakaryocytic leukemia29.8THPO, IL3, PF4, EPOR
28nephrotic syndrome29.8PPBP
29deficiency anemia29.7PPBP, G6PD, IFNA2, TIMP1, JAK2, MPL
30adenocarcinoma29.7PTPN6, ACP1, KITLG, PF4, EPOR, STAT5A
31atherosclerosis29.7PPBP, ITGB3, PF4, ACP1, SOCS3, TIMP1
32sarcoma29.7ACP1, THPO, KITLG, JAK2
33chronic myeloproliferative disease29.7THPO, MPL, JAK2
34pancytopenia29.7THPO, MPL, EPO, IL3
35hepatitis c29.7SOCS3, THPO, TIMP1, IFNA2
36purpura29.7THPO
37disseminated intravascular coagulation29.7THPO, PF4, PPBP
38tuberculosis29.7ACP1, PF4
39portal vein thrombosis29.7THPO
40eosinophilia29.7IFNA2, JAK2, IL3
41hemangioma29.7VHL, IFNA2
42congestive heart failure29.7EPO, EPOR, PPBP
43neurofibromatosis29.7VHL
44renal clear cell carcinoma29.7VHL, EPOR
45hypersplenism29.7THPO
46hemoglobinopathy29.7G6PD, EPO
47erythropoietin polycythemia10.6
48hypermanganesemia with dystonia polycythemia and cirrhosis10.4
49stress polycythemia10.3
50cerebritis10.3

Graphical network of the top 20 diseases related to Polycythemia:



Diseases related to polycythemia

Clinical Features for Polycythemia

About this section

Drugs & Therapeutics for Polycythemia

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials, 60UMLS, 40NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Polycythemia

Drug clinical trials:

Search ClinicalTrials for Polycythemia

Search NIH Clinical Center for Polycythemia

Search CenterWatch for Polycythemia

Genetic Tests for Polycythemia

About this section

Anatomical Context for Polycythemia

About this section
Sources:
32MalaCards
See all sources

MalaCards organs/tissues related to Polycythemia:

32
Bone marrow, Bone, Myeloid, Endothelial, Liver, Lung, Testes, B cells, Heart, T cells, Kidney, Whole blood, Fetal brain, Cortex, Prostate, Placenta, Skin, Spinal cord, Brain, Monocytes, Testis, Spleen, Cerebellum, Adrenal cortex

Animal Models for Polycythemia or affiliated genes

About this section
Sources:
36MGI
See all sources

Publications for Polycythemia

About this section
Sources:
50PubMed
See all sources

Articles related to Polycythemia:

(show top 50)    (show all 898)
idTitleAuthorsYear
1
Paraneoplastic symptoms: cachexia, polycythemia, and hypercalcemia are, respectively, related to vascular endothelial growth factor (VEGF) expression in renal clear cell carcinoma. (22534085)
2013
2
Treatment target in polycythemia vera. (23594012)
2013
3
Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management. (23695894)
2013
4
An unknown cause of aortic valve stenosis: polycythemia vera. (22843194)
2013
5
Chronic leg ulceration associated with polycythemia vera responding to ruxolitinib (Jakafi(Ar)). (23953278)
2013
6
Left main coronary thrombotic occlusion due to secondary polycythemia in a normal sinus of valsalva. (23913610)
2013
7
The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: A mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis. (24130064)
2013
8
Masked polycythemia Vera (mPV): Results of an international study. (23996471)
2013
9
The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W). (23403324)
2013
10
Age-related differences in disease characteristics and clinical outcomes in polycythemia vera. (23245211)
2013
11
Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera. (22160617)
2012
12
Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles. (22253704)
2012
13
Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis. (22659388)
2012
14
Protective effect of total flavonoids of seabuckthorn (Hippophae rhamnoides) in simulated high-altitude polycythemia in rats. (23023684)
2012
15
Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression. (21876117)
2011
16
Polycythemia and chorea. (21496586)
2011
17
Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia. (23049357)
2011
18
Manganese toxicity in a child with iron deficiency and polycythemia. (21596707)
2011
19
Polycythemia vera and pregnancy: experience of four pregnancies in a single patient. (20358212)
2011
20
Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980. (21911721)
2011
21
Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia. (20418246)
2010
22
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. (20631743)
2010
23
Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera. (19826111)
2009
24
Comprehensive geriatric assessment of elderly highlanders in Qinghai, China II: the association of polycythemia with lifestyle-related diseases among the three ethnicities. (20002753)
2009
25
An inhibitor of Janus kinase 2 prevents polycythemia in mice. (19413997)
2009
26
The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera. (19608683)
2009
27
Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors. (18394555)
2008
28
Prevalence of polycythemia vera and essential thrombocythemia. (18181200)
2008
29
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey. (17909074)
2008
30
HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera. (18059484)
2008
31
Synovial tumefactive extramedullary hematopoiesis associated to polycythemia vera. (17109152)
2007
32
How I treat patients with polycythemia vera. (17264301)
2007
33
JAK2 mutations in polycythemia vera--molecular mechanisms and clinical applications. (17267904)
2007
34
Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. (17674313)
2007
35
Polycythemia vera and its molecular basis: an update. (16781479)
2006
36
The diagnosis of polycythemia vera: new tests and old dictums. (16781483)
2006
37
Homozygous hemoglobin Tak causes symptomatic secondary polycythemia in a Thai boy. (12621249)
2003
38
Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease. (12829587)
2003
39
Acute leucocytoclastic vasculitis and aquagenic pruritus long preceding polycythemia rubra vera. (11978570)
2002
40
Increased cell surface expression of C-terminal truncated erythropoietin receptors in polycythemia. (11722595)
2001
41
Subacute Budd-Chiari syndrome associated with polycythemia vera and factor V Leiden mutation. (10924943)
2000
42
Pathogenesis of polycythemia vera. (9549927)
1998
43
Increased basal and induced tyrosine phosphorylation of the insulin-like growth factor I receptor beta subunit in circulating mononuclear cells of patients with polycythemia vera. (7542500)
1995
44
Large volume, isovolemic erythrocytapheresis in treatment of polycythemia vera. Effect of massive iron depletion of proliferation behavior of erythroid precursor cells (BFU-E)]. (7675003)
1995
45
In vitro sensitivity of human erythroid progenitors to hemopoietic growth factors: studies on primary and secondary polycythemia. (7806084)
1994
46
Polycythemia vera. (1587207)
1992
47
Polycythemia vera with der(15) and der(20) associated with remarkable neutrophilia]. (1779454)
1991
48
Hepatic vein thrombosis complicating polycythemia vera. Successful treatment with a portacaval shunt. (6028691)
1967
49
Blood basophils in primary polycythemia. (14400719)
1959
50
Polycythemia vera turning into myelofibrosis in an individual with Pelger-Huet anomaly of the leukocytes. (14435748)
1959

Genetic Variations for Polycythemia

About this section

Expression for genes affiliated with Polycythemia

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Polycythemia

Search GEO for disease gene expression data for Polycythemia.

Pathways for genes affiliated with Polycythemia

About this section
Sources:
51QIAGEN, 29KEGG, 53Reactome, 37NCBI BioSystems Database, 12EMD Millipore, 4Cell Signaling Technology, 52R&D Systems
See all sources

Pathways related to Polycythemia according to GeneCards/GeneDecks:

(show top 50)    (show all 56)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Hide members
10.8PPBP, JAK2, STAT5A, ITGB3, IL3, TIMP1
210.8JAK2, PTPN6, IL3, EPO, IFNA2, MPL
3
Hide members
10.8PPBP, THPO, TIMP1, JAK2, STAT5A, ITGB3
4
Hide members
10.8THPO, TIMP1, ITGB3, STAT5A, EPOR, JAK2
5
Hide members
10.8IFNA2, PPBP, TIMP1, JAK2, ITGB3, MPL
6
Hide members
10.8STAT5A, MPL, EPOR, IL3, JAK2, PPBP
7
Hide members
10.8PTPN6, IL3, TIMP1, PPBP, JAK2, KITLG
810.7IFNA2, KITLG, IL3, EPOR, EPO, ITGB3
9
Hide members
10.7PPBP, ITGB3, TIMP1, EPOR, IL3, THPO
1010.7THPO, ITGB3, EPO, EPOR, IL3, KITLG
11
Hide members
10.7EPO, STAT5A, JAK2, EPOR, PTPN6, ITGB3
12
Hide members
10.7PTPN6, JAK2, KITLG, EPOR, STAT5A, EPO
13
Development EPO-induced Jak-STAT pathway
Hide members
10.7EPOR, STAT5A, JAK2, SOCS3, EPO, PTPN6
14
Development Thrombopoetin signaling via JAK-STAT pathway
Hide members
10.7STAT5A, MPL, JAK2, SOCS3, PTPN6, THPO
15
Hide members
10.7IL3, TIMP1, EPOR, THPO, KITLG, PPBP
16
Hide members
10.7EPOR, PPBP, TIMP1, IL3, THPO, KITLG
17
Hide members
10.7THPO, KITLG, IL3, PPBP, TIMP1, EPOR
18
Hide members
10.7TIMP1, PPBP, IL3, KITLG, THPO, ITGB3
19
Hide members
10.7MPL, SOCS3, TIMP1, ITGB3, THPO, PPBP
20
Hide members
10.7PTPN6, IL3, STAT5A, JAK2, IFNA2, SOCS3
21
Hide members
10.7KITLG, JAK2, ITGB3, EPOR, EPO
22
Hide members
10.7THPO, KITLG, IL3, JAK2, PPBP
23
Hide members
10.7THPO, MPL, STAT5A, JAK2, SOCS3
2410.7JAK2, STAT5A, ITGB3, SOCS3, PTPN6
2510.7SOCS3, STAT5A, JAK2, IL3, PTPN6
26
Hide members
10.7JAK2, STAT5A, PTPN6, IL3, SOCS3
27
Immune response IL-2 activation and signaling pathway
Hide members
10.7SOCS3, JAK2, STAT5A, IL3, PTPN6
28
Hide members
10.6JAK2, KITLG, PTPN6, STAT5A
2910.6STAT5A, PTPN6, JAK2, SOCS3
3010.6SOCS3, JAK2, STAT5A, PTPN6
31
Hide members
10.6JAK2, SOCS3, STAT5A, PTPN6
3210.6JAK2, STAT5A, ITGB3, SOCS3
33
Hide members
10.6THPO, KITLG, PPBP, TIMP1
34
Development PDGF signaling via STATs and NF-kB
Hide members
10.6TIMP1, SOCS3, JAK2, STAT5A
35
Immune response Oncostatin M signaling via JAK-Stat in human cells
Hide members
10.6JAK2, SOCS3, TIMP1, STAT5A
36
Hide members
10.6PF4, STAT5A, JAK2, PPBP
37
Hide members
10.6ITGB3, PF4, PPBP, TIMP1
3810.6JAK2, EPO, EPOR
39
Hide members
10.6MPL, THPO, ITGB3
4010.6PTPN6, SOCS3, JAK2
4110.6PTPN6, STAT5A, JAK2
4210.6PTPN6, STAT5A, JAK2
4310.6ITGB3, PTPN6, VHL
4410.6TIMP1, SOCS3, JAK2
45
Development Leptin signaling via JAK/STAT and MAPK cascades
Hide members
10.6SOCS3, TIMP1, JAK2
4610.6TIMP1, ITGB3, VHL
4710.6JAK2, SOCS3, IFNA2
4810.6SOCS3, JAK2, STAT5A
4910.6STAT5A, SOCS3, JAK2
50
Immune response IFN alpha/beta signaling pathway
Hide members
10.6IFNA2, SOCS3, PTPN6

Compounds for genes affiliated with Polycythemia

About this section
Sources:
44Novoseek, 24HMDB, 49PharmGKB, 28IUPHAR, 11DrugBank, 59Tocris Bioscience, 2BitterDB
See all sources

Compounds related to Polycythemia according to GeneCards/GeneDecks:

(show top 50)    (show all 157)
idCompoundScoreTop Affiliating Genes
1tyrosine4411.6EPOR, PF4, IL3, KITLG, THPO, ACP1
2vegf4411.4PTPN6, ACP1, THPO, TIMP1, VHL, IFNA2
3phosphatidylinositol4411.4KITLG, IL3, EPOR, EPO, MPL, STAT5A
4alanine4411.4PTPN6, TIMP1, IFNA2, ACP1, THPO, KITLG
5cysteine4411.4EPOR, PF4, IL3, THPO, ACP1, PTPN6
6gp 1304411.3TIMP1, PTPN6, THPO, KITLG, IL3, EPOR
7thymidine44 2412.3PPBP, IFNA2, JAK2, STAT5A, EPOR, PF4
8agar4411.3JAK2, STAT5A, G6PD, EPOR, PF4, IL3
9ly2940024411.3EPO, THPO, IL3, KITLG, ACP1, EPOR
105-aza-2deoxycytidine4411.2EPO, JAK2, TIMP1, VHL, SOCS3, IL3
11aspirin44 49 28 2414.2ITGB3, G6PD, PF4, TIMP1, PPBP, KITLG
12rapamycin4411.2STAT5A, EPO, IL3, THPO, ACP1, JAK2
13hydroxyurea44 49 1113.2THPO, PF4, EPO, KITLG, JAK2, PPBP
14nitric oxide44 11 2413.2PTPN6, TIMP1, VHL, KITLG, EPOR, STAT5A
15serine4411.2MPL, EPOR, PTPN6, JAK2, G6PD, TIMP1
16lysine4411.2VHL, JAK2, IFNA2, SOCS3, ITGB3, MPL
17cisplatin44 49 59 1114.2ACP1, IFNA2, G6PD, JAK2, EPO, TIMP1
18lipid4411.2STAT5A, JAK2, PPBP, G6PD, IFNA2, PF4
19anagrelide44 1112.1PF4, EPO, MPL, JAK2, IFNA2, THPO
20oxygen44 2412.1PF4, EPOR, VHL, STAT5A, EPO, JAK2
21epinephrine44 11 2413.1ACP1, THPO, IFNA2, G6PD, KITLG, PF4
22cytarabine44 49 1113.1THPO, EPO, IL3, IFNA2, STAT5A, KITLG
23wortmannin4411.1IL3, KITLG, PF4, EPOR, JAK2, STAT5A
24actinomycin d4411.1TIMP1, VHL, G6PD, JAK2, IL3, THPO
25glucose4411.1SOCS3, IFNA2, KITLG, PPBP, PTPN6, PF4
26methylcellulose4411.1KITLG, TIMP1, IL3, EPOR, EPO, THPO
27herbimycin a44 5912.1JAK2, IL3, KITLG, ACP1, PTPN6, TIMP1
28genistein44 28 59 2 11 2416.1IL3, ACP1, THPO, KITLG, STAT5A, JAK2
29ribavirin44 49 1113.1IFNA2, SOCS3, G6PD, EPO, IL3, TIMP1
30pixy3214411.1IL3, KITLG, THPO, TIMP1, EPO
31iron44 2412.1KITLG, THPO, VHL, IFNA2, ITGB3, MPL
32filgrastim44 1112.0THPO, EPO, IL3, KITLG, IFNA2
33polyethylene glycol4411.0THPO, IFNA2, PF4, MPL, G6PD, KITLG
34lactate4411.0TIMP1, THPO, KITLG, IL3, PF4, G6PD
35aspartate4411.0JAK2, G6PD, STAT5A, ACP1, PTPN6
36phosphotyrosine4411.0SOCS3, JAK2, PTPN6, ACP1, IL3, EPOR
37etoposide44 49 59 1114.0TIMP1, ACP1, THPO, IL3, PF4, STAT5A
38estrogen4411.0THPO
39imatinib44 49 1112.9IL3, EPO, STAT5A, JAK2, KITLG, THPO
40gm-csf44 2811.9STAT5A, THPO
41histamine44 28 2412.9TIMP1, KITLG, IL3, THPO, PF4, PPBP
42amifostine44 1111.8KITLG, EPO, THPO, IL3
43h2o24410.8G6PD, PTPN6, THPO, KITLG, IL3, JAK2
44prostacyclin4410.8ACP1, PPBP, THPO, IL3, TIMP1, PF4
45butyrate4410.8JAK2, THPO, ACP1
46indomethacin44 59 28 1113.8PF4, ACP1
47cyclosporin a44 28 5912.7JAK2, ACP1, TIMP1, KITLG, IL3, EPO
48retinoic acid44 2411.7TIMP1, IFNA2, ACP1, PTPN6, STAT5A, IL3
49carboplatin44 49 1112.7THPO, IFNA2, IL3, EPO, KITLG
505fluorouracil4410.4MPL, PF4, IL3, IFNA2, KITLG, THPO

GO Terms for genes affiliated with Polycythemia

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Polycythemia according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:00561510.6THPO, IFNA2, PPBP, EPO, PF4, IL3
2platelet alpha granule lumenGO:03109310.6PF4, PPBP, TIMP1
3extracellular regionGO:00557610.5TIMP1, IFNA2, PPBP, EPO, EPOR, PF4

Biological processes related to Polycythemia according to GeneCards/GeneDecks:

(show all 20)
idNameGO IDScoreTop Affiliating Genes
1blood coagulationGO:00759611.2PTPN6, TIMP1, IFNA2, PPBP, JAK2, ITGB3
2platelet activationGO:03016811.0TIMP1, PPBP, ITGB3, MPL, PF4, THPO
3JAK-STAT cascade involved in growth hormone signaling pathwayGO:06039710.9SOCS3, JAK2, STAT5A, PTPN6
4positive regulation of peptidyl-tyrosine phosphorylationGO:05073110.9JAK2, ITGB3, IL3, KITLG
5cytokine-mediated signaling pathwayGO:01922110.9IFNA2, SOCS3, JAK2, PF4, PTPN6
6erythrocyte maturationGO:04324910.9EPO, G6PD, TIMP1
7regulation of interferon-gamma-mediated signaling pathwayGO:06033410.9SOCS3, JAK2, PTPN6
8platelet degranulationGO:00257610.9PF4, ITGB3, PPBP, TIMP1
9positive regulation of tyrosine phosphorylation of Stat5 proteinGO:04252310.9JAK2, EPO, IL3
10positive regulation of cell differentiationGO:04559710.8JAK2, SOCS3, VHL
11JAK-STAT cascadeGO:00725910.8STAT5A, JAK2, SOCS3
12regulation of type I interferon-mediated signaling pathwayGO:06033810.8IFNA2, SOCS3, PTPN6
13positive regulation of cell proliferationGO:00828410.7PTPN6, IL3, EPO, JAK2, TIMP1
14negative regulation of mast cell apoptotic processGO:03302610.7KITLG, STAT5A
15positive regulation of DNA replicationGO:04574010.7EPO, IL3, KITLG
16positive regulation of mast cell proliferationGO:07066810.7KITLG, STAT5A
17peptidyl-tyrosine phosphorylationGO:01810810.6JAK2, STAT5A, PTPN6
18type I interferon-mediated signaling pathwayGO:06033710.6PTPN6, SOCS3, IFNA2
19mammary gland epithelium developmentGO:06118010.4STAT5A, JAK2
20interferon-gamma-mediated signaling pathwayGO:06033310.3PTPN6, JAK2, SOCS3

Molecular functions related to Polycythemia according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1protein bindingGO:00551510.9ACP1, TIMP1, VHL, IFNA2, SOCS3, G6PD
2growth factor activityGO:00808310.5PPBP, IL3, KITLG, THPO
3cytokine activityGO:00512510.3THPO, KITLG, IL3, IFNA2

Products for genes affiliated with Polycythemia

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Polycythemia

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet